Detalles de la búsqueda
1.
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer
; 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38676430
2.
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium.
Int J Cancer
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709956
3.
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 35-45, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36085390
4.
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.
Gynecol Oncol
; 178: 110-118, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839313
5.
HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
BMC Cancer
; 22(1): 831, 2022 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907794
6.
Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis.
Eur J Clin Microbiol Infect Dis
; 40(9): 1791-1802, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34086102
7.
Secondary malignancies in long-term ovarian cancer survivors: results of the 'Carolin meets HANNA' study.
Int J Gynecol Cancer
; 31(5): 709-712, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649156
8.
Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.
Int J Gynecol Cancer
; 31(1): 98-103, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33127866
9.
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis.
Int J Gynecol Cancer
; 31(5): 713-720, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563640
10.
ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers.
Lancet Oncol
; 21(7): e360-e368, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32615119
11.
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 19(9): 1247-1258, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100379
12.
Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.
Br J Cancer
; 119(7): 847-854, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293997
13.
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Br J Cancer
; 119(3): 330-338, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955134
14.
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 46-47, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335272
15.
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Gynecol Oncol
; 150(1): 151-157, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753392
16.
Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience.
Int J Gynecol Cancer
; 28(8): 1491-1497, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30095708
17.
Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients: A Study of the Tumor Bank Ovarian Cancer Consortium.
Int J Gynecol Cancer
; 27(8): 1658-1665, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28691938
18.
Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Ann Surg Oncol
; 23(4): 1279-86, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26832880
19.
Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis.
Ann Surg Oncol
; 23(11): 3749-3756, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160526
20.
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium.
Tumour Biol
; 37(9): 12329-12337, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297669